Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT04459078 · UNKNOWN
Trial details
- NCT number
- NCT04459078
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2023-05-15
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.